Biodexa Pharmaceticals Correlations
| BDRX Stock | 7.77 0.57 6.83% |
The current 90-days correlation between Biodexa Pharmaceticals and Broadstone Net Lease is -0.08 (i.e., Good diversification). The correlation of Biodexa Pharmaceticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Biodexa Pharmaceticals Correlation With Market
Significant diversification
The correlation between Biodexa Pharmaceticals and DJI is 0.07 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Biodexa Pharmaceticals and DJI in the same portfolio, assuming nothing else is changed.
Moving together with Biodexa Stock
| 0.62 | VANI | Vivani Medical | PairCorr |
| 0.65 | AVH | Avita Medical | PairCorr |
| 0.62 | SABSW | SAB Biotherapeutics | PairCorr |
| 0.7 | ALA | Arovella Therapeutics | PairCorr |
| 0.64 | VRAX | Virax Biolabs Group | PairCorr |
Moving against Biodexa Stock
| 0.68 | EQ | Equillium | PairCorr |
| 0.46 | CMB | Cambium Bio | PairCorr |
| 0.32 | DMAC | DiaMedica Therapeutics Downward Rally | PairCorr |
| 0.58 | VSTM | Verastem | PairCorr |
| 0.54 | MRVL | Marvel Biosciences Corp | PairCorr |
Related Correlations Analysis
| -0.72 | 0.0 | 0.58 | 0.71 | 0.84 | BNL | ||
| -0.72 | 0.0 | -0.64 | -0.5 | -0.77 | BWEN | ||
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | MSBN | ||
| 0.58 | -0.64 | 0.0 | 0.17 | 0.71 | GSL | ||
| 0.71 | -0.5 | 0.0 | 0.17 | 0.63 | EA | ||
| 0.84 | -0.77 | 0.0 | 0.71 | 0.63 | BYDIF | ||
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Biodexa Stock performing well and Biodexa Pharmaceticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Biodexa Pharmaceticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| BNL | 0.87 | 0.24 | 0.25 | 0.58 | 0.51 | 2.46 | 4.64 | |||
| BWEN | 3.64 | (0.09) | (0.01) | 0.00 | 4.32 | 10.32 | 25.13 | |||
| MSBN | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| GSL | 1.13 | 0.02 | 0.01 | 0.06 | 1.39 | 2.05 | 7.68 | |||
| EA | 1.34 | 0.46 | 0.30 | 2.27 | 0.88 | 4.50 | 15.18 | |||
| BYDIF | 2.27 | 0.30 | 0.07 | 0.30 | 2.68 | 7.21 | 22.00 |
Biodexa Pharmaceticals Corporate Management
| Nicola Tuckwell | VP Operations | Profile | |
| Dmitry MD | Chief Officer | Profile | |
| Daniel MBA | Vice Technology | Profile | |
| Noreen Bhatti | Vice Operations | Profile | |
| Fiona Sharp | Group Controller | Profile | |
| Steve Ellul | Chief Officer | Profile |